Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles

María del Carmen Pingarrón Santofimia MD, Silvia Pilar González Rodríguez MD, PhD, Mariella Lilue MD, Santiago Palacios MD, PhD

Article Type

Case Report

Published

In this case report, outcomes in relation to bone homeostasis, bone mineral density (BMD), and osteopenia– osteoporosis are examined in postmenopausal women during treatment with ospemifene for vulvar and vaginal atrophy (VVA), a component of the genitourinary syndrome of menopause.

Read more

Ospemifene for vulvar and vaginal atrophy: an overview

Santiago Palacios MD, PhD

Article Type

Editorial

Published

This editorial article introduces a Special Focus Issue entitled “Treatment of Vulvar and Vaginal Atrophy: Clinical Experience with Ospemifene”. Ospemifene is a selective estrogen receptor modulator indicated for treatment of moderate-to-severe symptomatic vulvar and vaginal atrophy in postmenopausal women who are not candidates for local vaginal estrogen therapy or have contraindications for estrogen products.

Read more

Tics and Tourette’s syndrome

Shivam Om Mittal MD

Article Type

Review

Published

Tics and Tourette’s syndrome are common hyperkinetic movement disorders seen mostly in the pediatric age group. This review emphasizes the diagnosis and distinguishing of Tourette’s from other movement disorders.

Read more

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs

Alessandro Roggeri BSc, Ferruccio Conte MD, Carlotta Rossi MSc, Mario Cozzolino MD, PhD, Carlo Zocchetti MSc, Daniela Paola Roggeri MSc

Article Type

Original Research

Published

This retrospective observational study evaluated, in dialysis patients with SHPT, the impact of different levels of adherence to cinacalcet therapy on hospitalisations and direct healthcare costs charged to the Lombardy Regional Health Service (Italy).

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.